Y-mAbs Announces Data to be Presented at SIOP 2021
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (“Y-mAbs”, NASDAQ: YMAB), a commercial-stage biopharmaceutical company focused on...
Month: September 2021
Castellum, Inc. Announces Signing of LOI to Acquire $2 million Government Contractor
Castellum, Inc. Announces Signing of LOI to Acquire $2 million Government Contractor Castellum, Inc. (OTC: ONOV) announces the signing of...
Rakovina Therapeutics Presents Preclinical Data on novel kt-3000 Series Drug Candidates at JCA-AACR Precision Medicine International Conference
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) ("the Company"), a biopharmaceutical company committed...
TOMI iHP Disinfection Technology Passes EN 17272 Evaluation
FREDERICK, Md., Sept. 16, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Pure Extracts Ships Initial Order of Edible Gummies to Alberta
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
HMNC Brain Health Initiates Pioneering Precision Therapy Program in Mental Health
Pioneering the first large-scale double-blind studies to test the combination of therapies and genetic companion diagnostics in the area of...
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. First international patient enrolled in BrazilTrial approximately 75% enrolledrNAPc2...
Aileron Therapeutics Presents New Clinical Data at ESMO Virtual Congress 2021 Supporting ALRN-6924’s Best-in-Class Potential as a Chemoprotective Agent
Final results from completed Phase 1b trial in patients with small cell lung cancer (SCLC) receiving second-line topotecan demonstrated ALRN-6924’s...
Spero Therapeutics to Present Data at IDWeek 2021
CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
Research demonstrates the ability of Adaptive’s immune medicine platform to distinguish natural infection from vaccine response and the ability to...
Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event
BALA CYNWYD, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused...
eFFECTOR Therapeutics to Participate in 2021 Cantor Virtual Healthcare Conference
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in the development of selective translation...
Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners
Funds to be used to continue the clinical development of AZP-3601 for hypoparathyroidism while progressing AZP-3813 through IND-enabling activities in...
Monopar Initiates Open-Label Phase 1b Clinical Trial Evaluating Camsirubicin in Patients with Advanced Soft Tissue Sarcoma
WILMETTE, Ill., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary...
Alignment Healthcare Adds Arizona Priority Care to Provider Network
ORANGE, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the addition of...
AGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results Conference Call and Webcast on September 23, 2021
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
Palette Life Sciences Launches Newly Branded Website Featuring United States Portfolio
-Brand Refresh Showcases US and Global Commercial Products Dedicated to Treatment of Unmet Medical Needs- SANTA BARBARA, Calif. and STOCKHOLM,...
Reflect Scientific Inc. Expands Cryometrix Distribution Channel
OREM, Utah, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Ventegra Partners with Scipher Medicine For Patient-Centric Approach To Improve Outcomes and Lower Costs for Rheumatoid Arthritis Care
New PrismRA® blood test enables pharmacy benefit managers to use optimal approach to rheumatoid arthritis treatmentWALTHAM, Mass., Sept. 16, 2021 (GLOBE...
F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021
Preclinical Data Indicates a Broad Therapeutic Window for F-star’s First-in-Class Tetravalent Dual T cell AgonistCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass.,...
